| 摘要 |
FIELD: medicine, oncology, pharmacy. ^ SUBSTANCE: invention relates to drugs and concerns docetaxel as a drug used in accessory therapy for treatment of metastatic cancer breast in combination with doxorubicin and cyclophosphamide. Proposed combination of drugs provides the enhanced viability coefficient in patients with superexpressed glands ER, PR and/or HER2. ^ EFFECT: enhanced effectiveness of treatment. ^ 6 cl, 36 ex |
